Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RAMM Pharma Corp. Proxy Solicitation & Information Statement 2025

Jul 25, 2025

47859_rns_2025-07-25_d0002748-bdc1-4fab-b92b-167767a5aeb7.pdf

Proxy Solicitation & Information Statement

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

July 25, 2025

ODYSSEY

Filed via SEDAR+

To All Applicable Exchanges and Securities Administrators

Subject: Ramm Pharma Corp. (the "Issuer")
Notice of Meeting and Record Date - AMENDED

Dear Sir/Madam:

We are pleased to confirm the following information with respect to the Issuer's upcoming meeting of securityholders:

Meeting Type: Annual General Meeting
Meeting Date: August 29, 2025
Record Date for Notice of Meeting: July 23, 2025
Record Date for Voting (if applicable): July 23, 2025
Beneficial Ownership Determination Date: July 23, 2025
Class of Securities Entitled to Vote: Common
ISIN: CA75150G1046
Issuer sending proxy materials directly to NOBOs: No
Issuer paying for delivery to OBOs: Yes
Notice and Access for Beneficial Holders: No
Notice and Access for Registered Holders: No

In accordance with applicable securities regulations we are filing this information with you in our capacity as agent of the Issuer.

Yours truly,

Odyssey Trust Company
as agent for Ramm Pharma Corp.